The US Supreme Court has struck down a part of the bankruptcy deal for Purdue Pharma that would have shielded members of the Sackler family from future lawsuits over their role in fuelling the opioid crisis.
The Sacklers, who owned and operated the Oxycontin-maker for decades, had agreed to pay $6 billion toward a wider settlement in exchange for sweeping protections against civil claims related to the addictive opioid.
But the nation's top court ruled that granting such protections to those who did not themselves declare bankruptcy was not authorised under bankruptcy law.
It is a victory for the US government, which had challenged the deal, arguing that releasing the Sacklers was a misuse of the system.
comments powered by Disqus
All feeds
